News
ADVI in the News
Speed and oversight: FDA Commissioner Gottlieb acts on pledges
“Gottlieb is ‘a physician first,’ says Marc Samuels, founder and CEO of ADVI, a life sciences and healthcare services consulting firm in Washington, DC. Issues including vaccines, the opioid crisis and smoking transcend partisan or commercial considerations and are ‘more than just lip service,’ says Samuels.”
Lindsay Bealor Greenleaf Quoted in Modern Healthcare On Anthem’s New PBM
“This is an interesting side effect of insurers that are dealing with PBMs that they say aren’t passing along the rebates to insurers and ultimately the consumers.”, Greenleaf said
Michael Kolodziej, M.D., joins ADVI as Vice President and Chief Innovation Officer
ADVI Health LLC announced today that Michael (Mike) Kolodziej, M.D., joined the firm as Vice President and Chief Innovation Officer. In this role, Dr. Kolodziej will focus on supporting innovative alternative payment programs, including the Oncology Care Model and private payer initiatives, on behalf of lifescience, payer, and provider organizations in the US and globally.
Modern Healthcare interviewed Lindsay Bealor Greenleaf on resignation of HHS Secretary Price
***excerpt*** "Price ushered in a new era of slowing the pace of some of these dramatic payment models," said Republican healthcare analyst Lindsay Bealor Greenleaf, director at consultancy ADVI Health. "There's a difference between being forced to do something and doing something naturally. Not having him oversee the agency is disappointing."
Managed Healthcare Executive interviews Lindsay Bealor Greenleaf, Director at ADVI, about biosimilars
***excerpt*** "Biosimilars present an opportunity for cost savings in managed care, but the degree of savings will depend on physician prescribing behavior, biosimilar pricing and finalized guidance from the FDA on interchangeability," explains Lindsay Bealor Greenleaf, director at ADVI, a healthcare consulting firm that advises life science companies and provider organizations.
Angela Lively quoted in Pink Sheet
***excerpt*** "Industry stakeholders would certainly agree that the Medicare ESRD expanded bundle has stunted the interest in drug innovation in the dialysis market, though it would be difficult to prove such a claim," ADVI Chief Consulting Officer Angela Lively said.
As a key Obamacare rate deadline approaches, consumers and insurers are caught in limbo
Lindsay Bealor Greenleaf discussed the uncertain fate of the Obamacare exchanges with CNBC.
Marc Samuels Quoted in Pink Sheet
***excerpt*** "As commissioner he would keep a hard line and say that FDA is not in the business of advising on drug pricing or reimbursement or coverage of drugs. But they are in the business of efficacy and as part of efficacy, value." – Marc Samuels, founder and CEO of the ADVI consulting firm, said in an interview.
How Prescription Drugs Get Their Prices, Explained
ADVI Principal, Shefali Shah, was interviewed by Newsweek about the cost of new medication.
Lindsay Bealor Greenleaf Featured in Specialty Pharmacy Times
“When we talk about supply chain, we have to acknowledge the distortions that are in the marketplace. We had a recent Berkley Research Group study showing that manufacturers are retaining less than half of all spending on prescription drugs,” Lindsay Bealor Greenleaf, director at ADVI Health told Specialty Pharmacy Times. “We also had a recent CMS report showing that DIR fees are growing much faster than Part D costs. So, we’re starting off with a distorted marketplace. The biggest issue is patients aren’t really benefitting as much from this process as people might think.”
Marc Samuels and Lindsay Bealor Greenleaf quoted in BioPharma Dive
ADVI CEO Marc Samuels and Director Lindsay Bealor Greenleaf are quoted in BioPharma Dive’s look at why drug pricing seems so complicated. Both outline a roadmap for successful pricing strategy.
LINDSAY BEALOR GREENLEAF QUOTED IN STAT NEWS
ADVI Director Lindsay Bealor Greenleaf was interviewed about the role played by pharmacy benefit managers in the prescription drug supply chain.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.